A New Approach to Treating Brain Aneurysms: Inside the LuSeed DOME™ Implant

Treating brain aneurysms is still complex, and newer technologies have not solved every challenge.

In this episode of MedTech Unboxed, Steve talks with Nitzan Hirsh, Co-Founder and CEO of LuSeed Vascular, about the unmet need in aneurysm treatment and a new approach: the LuSeed DOME™, an intrasaccular implant designed to simplify treatment and improve long-term occlusion.

Nitzan walks through how current treatment options compare, where newer intrasaccular devices still fall short, and why LuSeed believes a more predictable, easier-to-size device can help expand treatment options.

This conversation also dives into the device’s dual-layer nitinol design, how procedural simplicity affects economics and cath lab efficiency, and why the technology was designed with robotics compatibility in mind.

What you’ll hear in this episode:

• Why aneurysms remain a major unmet need in neurovascular care, and how current treatment options still create tradeoffs for physicians and patients
• How coiling, stent-assisted treatment, flow diverters, and newer intrasaccular devices compare in aneurysm treatment
• What makes the LuSeed DOME™ different, including its dual-layer nitinol design and fully intrasaccular placement
• How procedural speed and simplicity can affect economics, hospital efficiency, and patient recovery
• How the team is thinking about early clinical progress, pivotal study preparation, and long-term commercialization